Analysts expect International Stem Cell CORP to report revenue of 10.55 M for 2019, against a range of 9.64 M to 11.47 M. The most recent reported year, 2018, came in at 11.09 M, a 1.1% beat against the 10.97 M consensus.
| Metric | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|
| Reported (Actual) | 7.46 M | 11.09 M | - | - |
| High Estimate | 7.29 M | 11.42 M | 11.47 M | 12.17 M |
| Low Estimate | 6.40 M | 10.51 M | 9.64 M | 10.66 M |
| Consensus Estimate | 6.85 M | 10.97 M | 10.55 M | 11.41 M |
Analysts expect International Stem Cell CORP to report earnings per share of -0.56 for 2019, against a range of -0.61 to -0.51. The most recent reported year, 2018, came in at -0.33 , in line with the -0.33 consensus.
| Metric | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|
| Reported (Actual) | -1.46 | -0.33 | - | - |
| High Estimate | -0.69 | -0.30 | -0.51 | -1.17 |
| Low Estimate | -0.79 | -0.36 | -0.61 | -1.31 |
| Consensus Estimate | -0.74 | -0.33 | -0.56 | -1.24 |